The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows
Abstract
Selective growth of T lymphocytes occurred when unfractionated normal human bone marrow cells were cultured with conditioned medium obtained from phytohemagglutinin-stimulated normal human lymphocytes (Ly-CM). Cultures of up to 90 percent T cells have been maintained for more than 9 months. The T cells exhibited a strict growth dependence upon Ly-CM and were consistently negative for Epstein-Barr viral information.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reedman, B. M., & Klein, G. (1973) · International Journal of Cancer · doi:10.1002/ijc.2910110302 · Cited by 1,668
(1972) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/49.3.891 · Cited by 916
Cited by
Items 101–145 of 145
Gartner, S. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03380170081023 · Cited by 319
Natural killer cells and cancer
Brittenden, J., Heys, S. D., Ross, J., & Eremin, O. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960401)77:7<1226::aid-cncr2>3.0.co;2-g · Cited by 319
Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content.
Cotner, T., Williams, J. M., Christenson, L., Shapiro, H. M., Strom, T. B., & Strominger, J. (1983) · The Journal of experimental medicine · doi:10.1084/jem.157.2.461 · Cited by 318
Two Hundred Years of Cancer Research
DeVita, V. T., & Rosenberg, S. A. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1204479 · Cited by 318
Cancer Immunotherapy Using Interleukin-2 and Interleukin-2-Activated Lymphocytes
Rosenberg, S. A., & Lotze, M. T. (1986) · Annual Review of Immunology · doi:10.1146/annurev.iy.04.040186.003341 · Cited by 314
Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know
Rosenberg, S. A. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.116 · Cited by 312
Interleukin 2: from immunostimulation to immunoregulation and back again
Bachmann, M. F., & Oxenius, A. (2007) · EMBO reports · doi:10.1038/sj.embor.7401099 · Cited by 303
Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy
Galstyan, A., Markman, J. L., Shatalova, E. S., Chiechi, A., Korman, A. J., Patil, R., Klymyshyn, D., Tourtellotte, W. G., Israel, L. L., Braubach, O., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11719-3 · Cited by 300
Kalyanaraman, V. S., Sarngadharan, M. G., Nakao, Y., Ito, Y., Aoki, T., & Gallo, R. C. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.5.1653 · Cited by 300
Self-citationRho, H. M., Poiesz, B., Ruscetti, F. W., & Gallo, R. C. (1981) · Virology · doi:10.1016/0042-6822(81)90642-5 · Cited by 299
Self-citationMier, J. W., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.10.6134 · Cited by 298
Self-citationThe virus of Japanese adult T-cell leukaemia is a member of the human T-cell leukaemia virus group
Popovic, M., Reitz, M. S., Sarngadharan, M. G., Robert-Guroff, M., Kalyanaraman, V. S., Nakao, Y., Miyoshi, I., Minowada, J., Yoshida, M., Ito, Y., et al. (1982) · Nature · doi:10.1038/300063a0 · Cited by 297
Self-citationRole of cytokines and inflammation in heart function during health and disease
Bartekova, M., Radosinska, J., Jelemensky, M., & Dhalla, N. S. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9716-x · Cited by 293
Croce, C. M., Isobe, M., Palumbo, A., Puck, J., Ming, J., Tweardy, D., Erikson, J., Davis, M., & Rovera, G. (1985) · Science · doi:10.1126/science.3919442 · Cited by 292
ICOS Co-Stimulation: Friend or Foe?
Wikenheiser, D. J., & Stumhofer, J. S. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00304 · Cited by 289
Crystal structure of the IL-2 signaling complex: Paradigm for a heterotrimeric cytokine receptor
Stauber, D. J., Debler, E. W., Horton, P. A., Smith, K. A., & Wilson, I. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511161103 · Cited by 288
Human T-lymphocyte growth factor: regulation of growth and function of T lymphocytes
Ruscetti, F., & Gallo, R. (1981) · Blood · doi:10.1182/blood.v57.3.379.379 · Cited by 288
Self-citationPoiesz, B. J., Ruscetti, F. W., Mier, J. W., Woods, A. M., & Gallo, R. C. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.11.6815 · Cited by 286
Self-citationWuest, S. C., Edwan, J. H., Martin, J. F., Han, S., Perry, J. S. A., Cartagena, C. M., Matsuura, E., Maric, D., Waldmann, T. A., & Bielekova, B. (2011) · Nature Medicine · doi:10.1038/nm.2365 · Cited by 284
Interleukin-2 and interleukin-15: immunotherapy for cancer
Fehniger, T. A., Cooper, M. A., & Caligiuri, M. A. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00021-1 · Cited by 280
Nicolini, A., Carpi, A., & Rossi, G. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.07.002 · Cited by 279
The role of cytokines in the regulation of NK cells in the tumor environment
Konjević, G. M., Vuletić, A. M., Mirjačić Martinović, K. M., Larsen, A. K., & Jurišić, V. B. (2019) · Cytokine · doi:10.1016/j.cyto.2019.02.001 · Cited by 279
Sequential expression of genes involved in human T lymphocyte growth and differentiation.
Krönke, M., Leonard, W. J., Depper, J. M., & Greene, W. C. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.6.1593 · Cited by 277
Holtrich, U., Wolf, G., Bräuninger, A., Karn, T., Böhme, B., Rübsamen-Waigmann, H., & Strebhardt, K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.5.1736 · Cited by 275
Fujita, T., Shibuya, H., Ohashi, T., Yamanishi, K., & Taniguchi, T. (1986) · Cell · doi:10.1016/0092-8674(86)90660-4 · Cited by 274
Cloning, sequence and expression of human interleukin-2 receptor
Cosman, D., Pat Cerretti, D., Larsen, A., Park, L., March, C., Dower, S., Gillis, S., & Urdal, D. (1984) · Nature · doi:10.1038/312768a0 · Cited by 272
Isolation of myelin basic protein-reactive T-cell lines from normal human blood
Burns, J., Rosenzweig, A., Zweiman, B., & Lisak, R. P. (1983) · Cellular Immunology · doi:10.1016/0008-8749(83)90250-2 · Cited by 266
Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment
Habanjar, O., Bingula, R., Decombat, C., Diab-Assaf, M., Caldefie-Chezet, F., & Delort, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044002 · Cited by 263
Rooney, J. W., Sun, Y.-L., Glimcher, L. H., & Hoey, T. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.11.6299 · Cited by 259
Cytokines and Immune Response in the Tumor Microenvironment
Mocellin, S., Wang, E., & Marincola, F. M. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200109000-00002 · Cited by 259
Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
Rosenzwajg, M., Churlaud, G., Mallone, R., Six, A., Dérian, N., Chaara, W., Lorenzon, R., Long, S. A., Buckner, J. H., Afonso, G., et al. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2015.01.001 · Cited by 257
Reitz, M. S., Poiesz, B. J., Ruscetti, F. W., & Gallo, R. C. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.3.1887 · Cited by 257
Self-citationSun, Z., Ren, Z., Yang, K., Liu, Z., Cao, S., Deng, S., Xu, L., Liang, Y., Guo, J., Bian, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11782-w · Cited by 211
Interleukin-2: Clinical applications
Atkins, M. B. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.33077 · Cited by 156
Advances in interleukin 2 receptor targeted treatment
Morris, J. C., & Waldmann, T. A. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.suppl_1.i109 · Cited by 131
Figueroa, J. A., Reidy, A., Mirandola, L., Trotter, K., Suvorava, N., Figueroa, A., Konala, V., Aulakh, A., Littlefield, L., Grizzi, F., et al. (2015) · International Reviews of Immunology · doi:10.3109/08830185.2015.1018419 · Cited by 78
Interleukin-2 production and activity in aged humans
Rabinowich, H., Goses, Y., Reshef, T., & Klajman, A. (1985) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(85)90081-8 · Cited by 73
T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities
Wang, Z., Li, B., Ren, Y., & Ye, Z. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00353 · Cited by 73
Long-term culture of monoclonal human T lymphocytes: models for immunosenescence?
Adibzadeh, M., Pohla, H., Rehbein, A., & Pawelec, G. (1995) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(95)01625-a · Cited by 64
Immunological classification of tumor types and advances in precision combination immunotherapy
Ren, X., Guo, S., Guan, X., Kang, Y., Liu, J., & Yang, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.790113 · Cited by 62
Immunomodulatory activity of β-Casein permeate medium fermented by lactic acid bacteria.
Laffineur, E., Genetet, N., & Leonil, J. (1996) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(96)76585-2 · Cited by 56
Vijapur, S. M., Yang, Z., Barton, D. J., Vaughan, L., Awan, N., Kumar, R. G., Oh, B.-M., Berga, S. L., Wang, K. K., & Wagner, A. K. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2019.6780 · Cited by 20
Role of Cytokines in Thymic Regulatory T Cell Generation: Overview and Updates
Tang, M., Jia, F., Nan, F., Zuo, F., Yuan, Z., & Zhang, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.883560 · Cited by 11
Cyclosporin a inhibits HTLV‐I tax expression and shows anti‐tumor effects in combination with VP‐16
Ozaki, A., Arima, N., Matsushita, K., Uozumi, K., Akimoto, M., Hamada, H., Kawada, H., Horai, S., Tanaka, Y., & Tei, C. (2007) · Journal of Medical Virology · doi:10.1002/jmv.21028 · Cited by 8
“IL-2 is a major cytokine produced by T cells and activates T cell functions [Morgan et al., 1976; Taniguchi et al., 1983].”
BackgroundGlobal HTLV-1/2 Burden and Associated Diseases
Williams, C. K. O. (2019) · Cancer and AIDS · doi:10.1007/978-3-319-99235-8_2 · Cited by 6
Metadata
- Authors
- Morgan, D. A., Ruscetti, F. W., & Gallo, R.
- Venue
- Science
- Published
- 1976-09-10
- Volume
- 193
- Issue
- 4257
- Pages
- 1007-1008
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2051962533
- Cited by
- 2,493
- References
- 2
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.